Big pharma, big data: Why drugmakers want your health records


  • TECH
  • Sunday, 04 Mar 2018

FILE PHOTO: A surgery nurse is seen beside the heart beat monitor in the operating theatre of the Unfallkrankenhaus Berlin (UKB) hospital in Berlin, Germany February 29, 2008. REUTERS/Fabrizio Bensch /File Photo

LONDON: Drugmakers are racing to scoop up patient health records and strike deals with technology companies as big data analytics start to unlock a trove of information about how medicines perform in the real world. 

Studying such real-world evidence offers manufacturers a powerful tool to prove the value of their drugs – something Roche aims to leverage, for example, with last month's US$2bil (RM7.81bil) purchase of Flatiron Health. 

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Tech News

EU monitoring new measures by Meta to tackle election disinformation
Klarna using GenAI to cut marketing costs by $10 million annually
OpenAI sets up Safety and Security Committee headed by senior executives
Google, Amazon, Apple lobby group opposes India's EU-like antitrust proposal
A tiny Mediterranean island wants a�piece of the global AI frenzy
UN hails RM22.53bil in new pledges to boost global connectivity
Man in Japan arrested for creating virus using generative AI systems
Sea unfairly favoured its own delivery service, Indonesia says
Smartphones can now last seven years. Here’s how to keep them working.
So long ICQ, the iconic ‘90s messaging platform that’s shutting after almost 30 years

Others Also Read